Report: Should Independent Drugstores Be More Accountable?
August 23, 2012
Inquiries into Improper Medicare Billing, Drug Diversion, and Drug Shortage Activities Raise Serious Questions Recent Congressional hearings and government investigations...
Filter by:
Research
Filter by Year:Clear Filters- Research
- Biosimilars
- Drug Abuse Prevention
- Drug Adherence Programs
- Drug Cost Management
- Drug Coupons & Assistance Programs
- Drug Coverage Mandates
- Drug Price Negotiations & Rebates
- Employers, Unions, & Insurers
- FEHB Program
- Formulary Design
- Fraud, Waste, & Abuse
- Generic Drug Utilization
- Health Insurance Marketplace (ACA)
- Home Delivery of Drugs
- Medicaid
- Medicare Part D
- Patient Cost Sharing
- Pharmacy Networks
- Pharmacy Reimbursement & Contracting
- REMS Management
- Specialty Benefit Design
- Specialty Pharmacies
- Specialty Pharmacy Networks
- TRICARE
The Cost of Independent Pharmacy Antitrust Exemptions, 2013-2017
March 28, 2012
H.R. 1946 Would Increase Costs by Up to $15.6 billion H.R. 1946 could increase direct costs to commercial payers by...
Pharmacy Distribution Channels for Narcotics and Other Controlled Substances
March 27, 2012
As policymakers seek to address the epidemic of prescription drug abuse and related pharmacy fraud and drug diversion, it is...
Key Findings from the National Survey of Independent Pharmacy Owners
March 15, 2012
North Star Opinion Research conducted a national telephone survey of 300 owners of independent pharmacies, asking about changes since the...
Savings Generated by New York’s Medicaid Pharmacy Reform
October 11, 2012
Executive Summary Medicaid is one of the nation’s few remaining programs in which public agencies still use a fee-for-service (FFS)...